{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:21:32Z","timestamp":1791069692151,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,1,5]],"date-time":"2014-01-05T00:00:00Z","timestamp":1388880000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s11926-013-0402-7","type":"journal-article","created":{"date-parts":[[2014,1,4]],"date-time":"2014-01-04T09:58:08Z","timestamp":1388829488000},"source":"Crossref","is-referenced-by-count":54,"title":["New Tests to Detect Antiphospholipid Antibodies: Anti-Domain\u00a0I Beta-2-Glycoprotein-I Antibodies"],"prefix":"10.1007","volume":"16","author":[{"given":"Cecilia Beatrice","family":"Chighizola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gerosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Meroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,5]]},"reference":[{"key":"402_CR1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295\u2013306.","journal-title":"J Thromb Haemost"},{"key":"402_CR2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","volume":"7","author":"PL Meroni","year":"2011","unstructured":"Meroni PL, Borghi MO, Raschi E, Tedesco F. Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheum. 2011;7:330\u20139.","journal-title":"Nat Rev Rheum"},{"key":"402_CR3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11926-010-0144-8","volume":"13","author":"B Laat de","year":"2011","unstructured":"de Laat B, de Groot PG. Autoantibodies directed against domain I of beta2-glycoprotein I. Curr Rheumatol Rep. 2011;13:70\u20136.","journal-title":"Curr Rheumatol Rep"},{"key":"402_CR4","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1177\/0961203312437439","volume":"21","author":"L Pelkmans","year":"2012","unstructured":"Pelkmans L, de Laat B. Antibodies against domain I of be-glycoprotein I: the one and only? Lupus. 2012;21:769\u201372.","journal-title":"Lupus"},{"key":"402_CR5","doi-asserted-by":"crossref","first-page":"6939","DOI":"10.1182\/blood-2010-12-325951","volume":"117","author":"C Agar","year":"2011","unstructured":"\u2022\u2022 Agar C, de Groot PG, M\u00f6rgelin M, et al. Beta2-Glycoprotein I: a novel component of innate immunity. Blood. 2011;117:6939\u201347. This paper describes the interaction between \u03b2 2 GPI and LPS.","journal-title":"Blood"},{"key":"402_CR6","doi-asserted-by":"crossref","first-page":"42494","DOI":"10.1074\/jbc.M111.230383","volume":"286","author":"P Laplante","year":"2011","unstructured":"Laplante P, Amireault P, Subang R, et al. Interaction of \u03b22-glycoprotein I with lipopolysaccharide leads to Toll-like receptor 4 (TLR4)-dependent activation of macrophages. J Biol Chem. 2011;286:42494\u2013503.","journal-title":"J Biol Chem"},{"key":"402_CR7","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/0961203309360544","volume":"19","author":"Y Ioannou","year":"2010","unstructured":"Ioannou Y, Rahman A. Domain I of \u03b22-glycoprotein I: its role as an epitope and the potential to be developed as a specific target for the treatment of the antiphospholipid syndrome. Lupus. 2010;19:400\u20135.","journal-title":"Lupus"},{"key":"402_CR8","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1182\/blood-2009-12-260976","volume":"116","author":"C Agar","year":"2010","unstructured":"Agar C, van Os GM, Morgelin M, et al. Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome. Blood. 2010;116:1336\u201343.","journal-title":"Blood"},{"key":"402_CR9","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1093\/emboj\/18.19.5166","volume":"18","author":"B Bouma","year":"1999","unstructured":"Bouma B, de Groot PG, van den Elsen JM, et al. Adhesion mechanism of human beta(2)-glycoprotein I to phospholipid based on its crystal structure. EMBO J. 1999;18:5166\u201374.","journal-title":"EMBO J"},{"key":"402_CR10","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1093\/emboj\/18.22.6228","volume":"18","author":"R Schwarzenbacher","year":"1999","unstructured":"Schwarzenbacher R, Zeth K, Diederichs K, et al. Crystal structure of human beta2-glyoprotein I: implications for phospholipid binding and the antiphospholipid syndrome. EMBO J. 1999;18:6228\u201339.","journal-title":"EMBO J"},{"key":"402_CR11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0022-2836(02)00621-6","volume":"321","author":"M Hammel","year":"2002","unstructured":"Hammel M, Kriechbaum M, Gries A, et al. Solution structure of human and bovine beta(2)-glycoprotein I revealed by small-angle x-ray scattering. J Mol Biol. 2002;321:85\u201397.","journal-title":"J Mol Biol"},{"key":"402_CR12","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.4049\/jimmunol.160.8.3917","volume":"160","author":"J George","year":"1998","unstructured":"George J, Gilburd B, Hojnik M, et al. Target recognition of \u03b22-glycoprotein I (\u03b22GPI)-dependent anticardiolipin antibodies: evidence for involvement of the fourth domain of \u03b22GPI in antibody binding. J Immunol. 1998;160:3917\u201323.","journal-title":"J Immunol"},{"key":"402_CR13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/096120339800700204","volume":"7","author":"T Koike","year":"1998","unstructured":"Koike T, Ichikawa K, Kasahara H, Atsumi T, Tsutsumi A, Matsuura E. Epitopes on \u03b22-glycoprotein I recognized by anticardiolipin antibodies. Lupus. 1998;7:14\u20137.","journal-title":"Lupus"},{"key":"402_CR14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s002960050046","volume":"18","author":"CD Yang","year":"1998","unstructured":"Yang CD, Chen SL, Shen N, Qi M, Xu F. Detection of anti-recombinant \u03b22 glycoprotein I fifth domain antibodies in sera from patients with systemic lupus erythematosus. Rheumatol Int. 1998;18:5\u201310.","journal-title":"Rheumatol Int"},{"key":"402_CR15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1055\/s-0037-1615218","volume":"80","author":"J Arvieux","year":"1998","unstructured":"Arvieux J, Regnault V, Hachulla E, Darnige L, Roussel B, Bensa JC. Heterogeneity and immunochemical properties of anti-b2-glycoprotein I autoantibodies. Thromb Haemost. 1998;80:393\u20138.","journal-title":"Thromb Haemost"},{"key":"402_CR16","doi-asserted-by":"crossref","unstructured":"Blank M, Shoenfeld Y, Cabilly S, Heldman Y, Fridkin M, Katchalski-Katzir E: Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides. Proc Natl Acad Sci USA 1999, 5164\u20135168.","DOI":"10.1073\/pnas.96.9.5164"},{"key":"402_CR17","doi-asserted-by":"crossref","first-page":"15542","DOI":"10.1073\/pnas.95.26.15542","volume":"95","author":"GM Iverson","year":"1998","unstructured":"Iverson GM, Victoria EJ, Marquis DM. Anti-\u03b22 glycoprotein I (\u03b22GPI) autoantibodies recognize an epitope on the first domain of \u03b22GPI. Proc Natl Acad Sci U S A. 1998;95:15542\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"402_CR18","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1055\/s-0037-1616091","volume":"86","author":"PA McNeely","year":"2001","unstructured":"McNeely PA, Dlott JS, Furie RA, et al. \u03b22-glycoprotein I-dependent anticardiolipin antibodies preferentially bind the amino terminal domain of \u03b22-glycoprotein I. Thromb Haemost. 2001;86:590\u20135.","journal-title":"Thromb Haemost"},{"key":"402_CR19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/jaut.2000.0427","volume":"15","author":"SW Reddel","year":"2000","unstructured":"Reddel SW, Wang YX, Sheng YH, Krillis SA. Epitope studies with anti-\u03b22-glycoprotein I antibodies from autoantibody and immunized sources. J Autoimmunity. 2000;15:91\u20136.","journal-title":"J Autoimmunity"},{"key":"402_CR20","doi-asserted-by":"crossref","first-page":"7097","DOI":"10.4049\/jimmunol.169.12.7097","volume":"169","author":"GM Iverson","year":"2002","unstructured":"Iverson GM, Reddel S, Victoris EJ, et al. Use of single point mutations in domain I of \u03b22-glycoprotein I to determine fine antibody specificity of antiphospholipid autoantibodies. J Immunol. 2002;169:7097\u2013103.","journal-title":"J Immunol"},{"key":"402_CR21","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/art.22306","volume":"56","author":"Y Ioannou","year":"2007","unstructured":"Ioannou Y, Pericleous C, Giles I, Latchman DS, Isenberg DA, Rahman A. Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human beta(2)-glycoprotein I: mutation studies including residues R39 to R43. Arthritis Rheum. 2007;56:280\u201390.","journal-title":"Arthritis Rheum"},{"key":"402_CR22","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1182\/blood-2005-05-1943","volume":"107","author":"B Laat de","year":"2006","unstructured":"de Laat B, Derksen RH, van Lummel M, et al. Pathogenic anti-beta2 glycoprotein I antibodies recognize domain I of beta-2\u00a0glycoprotein I only after a conformational change. Blood. 2006;107:1916\u201324.","journal-title":"Blood"},{"key":"402_CR23","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1002\/art.30633","volume":"63","author":"B Laat De","year":"2011","unstructured":"\u2022\u2022 De Laat B, van Berkel M, Urbanus RT, et al. Immune responses against domain I of \u03b22-glycoprotein I are driven by conformational changes. Arthritis Rheum. 2011;63:3960\u20138. In vivo immunization against DI depends upon \u03b2 2 GPI conformation.","journal-title":"Arthritis Rheum"},{"key":"402_CR24","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMra1112830","volume":"368","author":"B Giannakopoulos","year":"2013","unstructured":"Giannakopoulos B, Krillis SA. The pathogenesis of the anti-phospholipid syndrome. N Eng J Med. 2013;368:1033\u201344.","journal-title":"N Eng J Med"},{"key":"402_CR25","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1002\/art.30383","volume":"63","author":"Y Ioannou","year":"2011","unstructured":"Ioannou Y, Zhang JY, Qi M, et al. Novel assays of thrombogenic pathogenicity for the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen \u03b22-glycoprotein I. Arthritis Rheum. 2011;63:2774\u201382.","journal-title":"Arthritis Rheum"},{"key":"402_CR26","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2005-03-1319","volume":"106","author":"F Fischetti","year":"2005","unstructured":"Fischetti F, Durigutto P, Pellis V, et al. Thrombus formation induced by antibodies to \u03b22-glycoprotein I is complement dependent and requires a priming factor. Blood. 2005;106:2340\u20136.","journal-title":"Blood"},{"key":"402_CR27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.autrev.2012.05.006","volume":"12","author":"M Mahler","year":"2012","unstructured":"Mahler M, Norman GL, Meroni PL, Khamashta M. Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndrome. Autoimmun Rev. 2012;12:313\u20137.","journal-title":"Autoimmun Rev"},{"key":"402_CR28","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1182\/blood-2004-09-3387","volume":"105","author":"B Laat de","year":"2005","unstructured":"de Laat B, Derksen RH, Urbanus RT, de Groot PG. IgG antibodies that recognize epitope Gly40-Arg43 in domain I of \u03b22-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood. 2005;105:1540\u20135.","journal-title":"Blood"},{"key":"402_CR29","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1538-7836.2009.03316.x","volume":"7","author":"Y Ioannou","year":"2009","unstructured":"Ioannou Y, Romay-Penabad Z, Pericleous C, et al. In vivo inhibition of antiphospholipid antibody-induced pathogenicity utilizing the antigenic target peptide domain I of \u03b22-glycoprotein I: proof of concept. J Thromb Haemost. 2009;7:833\u201342.","journal-title":"J Thromb Haemost"},{"key":"402_CR30","doi-asserted-by":"crossref","first-page":"S740","DOI":"10.1002\/art.33390","volume":"64","author":"C Pericleous","year":"2012","unstructured":"Pericleous C, Ruiz-Limon P, Romay-Penabad Z, et al. Affinity purified antibodies directed to domain I of \u03b22GPI are pathogenic in a mouse model of thrombosis. Arthritis Rheum. 2012;64:S740.","journal-title":"Arthritis Rheum"},{"key":"402_CR31","first-page":"S245","volume":"65","author":"C Agostinis","year":"2013","unstructured":"\u2022\u2022 Agostinis C, Durigutto P, Sblattero D, et al. A human recombinant antibody to beta2-glycoprotein I prevents thrombus formation and fetal loss in animal models of anti-phospholipid syndrome. Arthritis Rheum. 2013;65:S245. This work provides direct evidence of the pathogenicity of anti-DI antibodies.","journal-title":"Arthritis Rheum"},{"key":"402_CR32","doi-asserted-by":"crossref","first-page":"e71402","DOI":"10.1371\/journal.pone.0071402","volume":"8","author":"L Pelkmans","year":"2013","unstructured":"Pelkmans L, Kelchtermans H, de Groot PG, Zuily S, Regnault V, et al. Variability in Exposure of Epitope G40-R43 of Domain I in Commercial Anti-Beta2-Glycoprotein I IgG ELISAs. PLoS ONE. 2013;8:e71402. doi: 10.1371\/journal.pone.0071402 .","journal-title":"PLoS ONE"},{"key":"402_CR33","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.cca.2012.01.004","volume":"413","author":"M Mahler","year":"2012","unstructured":"Mahler M, Radice A, Yang W, et al. Development and performance evaluation of novel chemiluminescence assays for detection of anti-PR3 and anti-MPO antibodies. Clin Chim Acta. 2012;413:719\u201326.","journal-title":"Clin Chim Acta"},{"key":"402_CR34","unstructured":"Borghi MO, Grossi C, Pregnolato F, et al. Anti-beta2 glycoprotein I-domain I autoantibodies: comparison between two methods of detection [abstract]. Granada: VIII Congress on Autoimmunity; 2012."},{"key":"402_CR35","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/art.38066","volume":"65","author":"R Willis","year":"2013","unstructured":"Willis R, Mahler M, Pregnolato F, et al. Clinical evaluation of two anti-Beta2glycoprotein I Domain 1 autoantibody assays to aid in the diagnosis and risk assessment of the antiphospholipid syndrome. Arthritis Rheum. 2013;65:S3.","journal-title":"Arthritis Rheum"},{"key":"402_CR36","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1002\/acr.21904","volume":"65","author":"N Zohoury","year":"2013","unstructured":"Zohoury N, Khamashta M, Atsumi T, et al. Autoantibodies targeting Domain 1 of beta 2 glycoprotein I as promising marker in the diagnosis and risk stratification of the antiphospholipid syndrome. Arthritis Rheum. 2013;65:S4.","journal-title":"Arthritis Rheum"},{"key":"402_CR37","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/pro.387","volume":"19","author":"N Pozzi","year":"2010","unstructured":"Pozzi N, Banzato A, Bettin S, Bison E, Pengo V, De Filippis V. Chemical synthesis and characterization of wild-type and biotinylated N-terminal domain 1\u201364 of beta2-glycoprotein I. Protein Sci. 2010;19:1065\u201378.","journal-title":"Protein Sci"},{"key":"402_CR38","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.thromres.2011.04.021","volume":"128","author":"A Banzato","year":"2011","unstructured":"\u2022 Banzato A, Pozzi N, Frasson R, et al. Antibodies to Domain I of beta(2)Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS). Thromb Res. 2011;128:583\u20136. In this work, anti-DI antibodies were associated with high-risk triple positivity.","journal-title":"Thromb Res"},{"key":"402_CR39","unstructured":"Albesa R, Zohoury N, Pierangeli SS, Iverson GM, Norman GM: Performance of a novel chemiluminescent test for detection of antibodies to \u03b22GPI-domain I in patients with anti-phospholipid syndrome (APS) [abstract]. Granada: VIII Congress on Autoimmunity; 2012."},{"key":"402_CR40","volume-title":"Antibodies against domain I of beta2-glycoprotein I are a better predictor for the antiphospholipid syndrome than antibodies to the total protein [abstract]","author":"M Hollestelle","year":"2013","unstructured":"Hollestelle M, van Schangen M, Kariman A, Pequeriaux N. Antibodies against domain I of beta2-glycoprotein I are a better predictor for the antiphospholipid syndrome than antibodies to the total protein [abstract]. Amsterdam: XXIV Congress of the international society of thrombosis and haemostasis; 2013."},{"key":"402_CR41","volume-title":"Antibodies (IgG) to domain I of beta 2 glycoprotein I (\u03b22GPI-domain I) measured by a novel chemiluminiscence assay [abstract]","author":"R Albesa","year":"2012","unstructured":"Albesa R, Khamashta M, Shums Z, Zohoury N, Norman G, Mahler M. Antibodies (IgG) to domain I of beta 2 glycoprotein I (\u03b22GPI-domain I) measured by a novel chemiluminiscence assay [abstract]. Granada: 8th International Congress on Autoimmunity; 2012."},{"key":"402_CR42","first-page":"101","volume":"2003","author":"M Galli","year":"1827","unstructured":"Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood. 1827;2003:101.","journal-title":"Blood"},{"key":"402_CR43","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1111\/j.1538-7836.2009.03588.x","volume":"7","author":"B Laat de","year":"2009","unstructured":"de Laat B, Pengo V, Pabinger I, et al. The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study. J Thromb Haemost. 2009;7:1767\u201373.","journal-title":"J Thromb Haemost"},{"key":"402_CR44","doi-asserted-by":"crossref","first-page":"S1130","DOI":"10.1002\/art.37871","volume":"65","author":"S Zuily","year":"2013","unstructured":"Zuily S, De Laat B, Regnault V, et al. Autoantibodies against domain I of beta2-glycoprotein indicate an increased risk for thrombosis in antiphospholipid patients. A prospective cohort study. Arthritis Rheum. 2013;65:S1130.","journal-title":"Arthritis Rheum"},{"key":"402_CR45","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/art.38216","volume":"65","author":"N Agmon-Levin","year":"2013","unstructured":"Agmon-Levin N, Seguro L, Rosario C, et al. Anti-\u03b22GPI-DI antibodies are a marker of APS severity. Arthritis Rheum. 2013;65:S1.","journal-title":"Arthritis Rheum"},{"key":"402_CR46","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1002\/acr.21904","volume":"65","author":"L Andreoli","year":"2013","unstructured":"Andreoli L, Nalli C, Borghi MO, et al. Domain I is the main specificity of anti-beta2 GPI in systemic autoimmune diseases. Arthritis Rheum. 2013;65:S4.","journal-title":"Arthritis Rheum"},{"key":"402_CR47","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/ard.2010.137281","volume":"70","author":"L Andreoli","year":"2011","unstructured":"Andreoli L, Nalli C, Motta M, et al. Anti-\u03b22-glycoprotein I IgG antibodies from 1-year old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4\/5: might it be the reason of their innocent profile? Ann Rheum Dis. 2011;70:380\u20133.","journal-title":"Ann Rheum Dis"},{"key":"402_CR48","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1182\/blood-2006-07-030148","volume":"109","author":"B Laat de","year":"2007","unstructured":"de Laat B, Wu X-X, van Lummel M, Derksen RHWM, de Groot PG, Rand JH. Correlation between antiphospholipid antibodies that recognize domain I of \u03b22-glycoprotein I and a reduction in the anticoagulation activity of annexin A5. Blood. 2007;109:1490\u20134.","journal-title":"Blood"},{"key":"402_CR49","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1177\/0961203313490241","volume":"22","author":"DM Wahezi","year":"2013","unstructured":"Wahezi DM, Ilowite NT, Pelkmans L, de Laat B, Schanberg LE, Rand JH. Annexin A5 anticoagulant activity in children with systemic lupus erythematosus and the association with antibodies to domain I of \u03b22 glycoprotein I. Lupus. 2013;22:702\u201311.","journal-title":"Lupus"},{"key":"402_CR50","first-page":"S743","volume":"64","author":"AB Levine","year":"2012","unstructured":"Levine AB, Rand JH, Wu XX, et al. Effects of hydroxychloroquine (HCQ) on the Annexin A5 resistance assay (AnnA5-RA) in antiphospholipid antibody (aPL) positive patients: preliminary results of an ongoing prospective study. Arthritis Rheum. 2012;64:S743.","journal-title":"Arthritis Rheum"},{"key":"402_CR51","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1182\/blood-2004-01-0203","volume":"104","author":"JH Rand","year":"2004","unstructured":"Rand JH, Wu XX, Lapinski R, et al. Detection of antibody-mediated reduction of annexin A5 anti-coagulant activity in plasmas of patients with the antiphospholipid syndrome. Blood. 2004;104:2783\u201390.","journal-title":"Blood"},{"key":"402_CR52","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0002-9440(10)63479-7","volume":"163","author":"JH Rand","year":"2003","unstructured":"Rand JH, Wu XX, Quinn AS, et al. Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay. Am J Pathol. 2003;163:1193\u2013200.","journal-title":"Am J Pathol"},{"key":"402_CR53","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.autrev.2012.11.008","volume":"12","author":"V Pengo","year":"2013","unstructured":"Pengo V, Banzato A, Denas G, et al. Correct laboratory approach to APS diagnosis and monitoring. Autoimmun Rev. 2013;12:832\u20134.","journal-title":"Autoimmun Rev"},{"key":"402_CR54","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1111\/jth.12264","volume":"11","author":"V Pengo","year":"2013","unstructured":"Pengo V, Ruffatti A, Del Ross T, et al. Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile. J Thromb Haemost. 2013;11:1527\u201332.","journal-title":"J Thromb Haemost"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-013-0402-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-013-0402-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-013-0402-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T15:09:37Z","timestamp":1716390577000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-013-0402-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,5]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["402"],"URL":"https:\/\/doi.org\/10.1007\/s11926-013-0402-7","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,5]]},"article-number":"402"}}